Abstract
The effects of pneumococcal conjugated vaccines (PCVs) need to be investigated. In Stockholm County, Sweden, PCV7 was introduced in the childhood immunisation programme in 2007 and changed to PCV13 in 2010.
Over 90% of all invasive isolates during 2005–2014 (n=2336) and carriage isolates, 260 before and 647 after vaccine introduction, were characterised by serotyping, molecular typing and antibiotic susceptibility, and serotype diversity was calculated. Clinical information was collected for children and adults with invasive pneumococcal disease (IPD).
The IPD incidence decreased post-PCV7, but not post-PCV13, in vaccinated children. Beneficial herd effects were seen in older children and adults, but not in the elderly. The herd protection was more pronounced post-PCV7 than post-PCV13. PCV7 serotypes decreased. IPD caused by PCV13 serotypes 3 and 19A increased post-PCV7. Post-PCV13, serotypes 6A and 19A, but not serotype 3, decreased. The serotype distribution changed in carriage and IPD to nonvaccine types, also in nonvaccinated populations. Expansion of non-PCV13 serotypes was largest following PCV13 introduction. Serotype diversity increased and nonvaccine clones emerged, such as CC433 (serotype 22F) in IPD and CC62 (serotype 11A) in carriage. In young children, meningitis, septicaemia and severe rhinosinusitis, but not bacteraemic pneumonia, decreased.
Pneumococcal vaccination leads to expansion of new or minor serotypes/clones, also in nonvaccinated populations.
Abstract
New or minor serotypes/clones expanded, also in nonvaccinated populations, affecting future vaccine strategies http://ow.ly/VA9EO
Footnotes
This article has supplementary material available from erj.ersjournals.com
Support statement: This work was supported by grants from the Swedish Research Council, the Stockholm County Council (ALF grant), the Swedish Foundation for Strategic research (SSF), and Knut and Alice Wallenberg foundation. Funding information for this article has been deposited with FundRef.
Conflict of interest: None declared.
- Received August 31, 2015.
- Accepted December 1, 2015.
- Copyright ©ERS 2016
ERJ Open articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.